Synopsis
Synopsis
0
VMF
0
Australia
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. D-methorphan
2. Dextromethorphan
3. Dextromethorphan Hydrobromide
4. Dextromethorphan Hydrobromide, (+-)-isomer
5. Dextromethorphan Hydrobromide, Monohydrate
6. Dextromethorphan Hydrochloride
7. Dextromethorphan, (+-)-isomer
8. Hydrobromide, Dextromethorphan
9. Hydrochloride, Dextromethorphan
10. L-methorphan
11. Levomethorphan
12. Racemethorphan
1. Dextromethorphan Hydrobromide
2. 125-69-9
3. Antussan
4. Demorphan
5. Dormethan
6. Metrorat
7. Medicon
8. Tusilan
9. Tussade
10. D-methorphan Hydrobromide
11. Romilar
12. Methorate Hydrobromide
13. Dextromethorphan Bromide
14. Dextromethorphan (hydrobromide)
15. Dextromethorphan Hydrobromide Anhydrous
16. Ro 1-5470/5
17. Dextromethorphan Hbr
18. D-3-methoxy-n-methylmorphinan Hydrobromide
19. Z0cg3115fg
20. Benylin Dm
21. (1s,9s,10s)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrobromide
22. Romilar Hydrobromide
23. (9?,13?,14?)-3-methoxy-17-methylmorphinan Hydrobromide
24. Dextroramin P
25. Demorphine
26. Dextrometorphan Hydrobromide
27. Allfen-dm
28. (1s,9s,10r)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;hydrobromide
29. Nsc-756723
30. Demorphan Hydrobromide
31. Einecs 204-750-1
32. Dextromethorphan Polistirex
33. (9alpha,13alpha,14alpha)-3-methoxy-17-methylmorphinan Hydrobromide
34. Unii-z0cg3115fg
35. Canfodion
36. Cosylan
37. Dormetan
38. Hihustan M.
39. Ro 1-5470
40. Dxm Hbr
41. 9-alpha,13-alpha,14-alpha-morphinan, 3-methoxy-17-methyl-, Hydrobromide
42. Schembl121924
43. Morphinan, 3-methoxy-n-methyl-, Hydrobromide, (+)-
44. Chembl1201004
45. Dtxsid60872346
46. Bcp06595
47. Hy-b0620
48. Dextromethorphan Hbr Anhydrous
49. Mfcd00269810
50. Akos022186323
51. Ccg-212567
52. Nsc 756723
53. Dextromethorphan Hydrobromide [mi]
54. Dextromethorphan Hydrobromide [who-dd]
55. Q27294835
56. (9alpha,13alpha,14alpha)-3-methoxy-17-methylmorphinan Hbr
57. 3-methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan Hbr
58. Morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-, Hydrobromide
59. 3-methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan Hydrobromide
60. 9alpha,13alpha,14alpha-morphinan, 3-methoxy-17-methyl-, Hydrobromide (8ci)
61. Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-, Hbr
62. Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-, Hydrobromide
63. Morphinan, 3-methoxy-17-methyl-, Hydrobromide (1:1),(9.alpha.,13.alpha.,14.alpha.)-
64. (4bs,8as,9s)-3-methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5h-9,4b-(epiminoethano)phenanthrene Hydrobromide
65. 1887136-04-0
| Molecular Weight | 352.3 g/mol |
|---|---|
| Molecular Formula | C18H26BrNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 351.11978 g/mol |
| Monoisotopic Mass | 351.11978 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 370 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Delsym |
| Active Ingredient | Dextromethorphan polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 30mg hbr/5ml |
| Market Status | Over the Counter |
| Company | Reckitt Benckiser |
| 2 of 4 | |
|---|---|
| Drug Name | Dextromethorphan polistirex |
| Active Ingredient | Dextromethorphan polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 30mg hbr/5ml |
| Market Status | Over the Counter |
| Company | Tris Pharma |
| 3 of 4 | |
|---|---|
| Drug Name | Delsym |
| Active Ingredient | Dextromethorphan polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 30mg hbr/5ml |
| Market Status | Over the Counter |
| Company | Reckitt Benckiser |
| 4 of 4 | |
|---|---|
| Drug Name | Dextromethorphan polistirex |
| Active Ingredient | Dextromethorphan polistirex |
| Dosage Form | Suspension, extended release |
| Route | Oral |
| Strength | eq 30mg hbr/5ml |
| Market Status | Over the Counter |
| Company | Tris Pharma |
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Mighty Chews consisting, Dextromethorphan HBr, is the first and only over-the-counter medicated children's soft chew for cough relief.
Lead Product(s): Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Mighty Chews
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 30, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Mucinex Children's Launches Mighty Chews
Details : Mighty Chews consisting, Dextromethorphan HBr, is the first and only over-the-counter medicated children's soft chew for cough relief.
Product Name : Mighty Chews
Product Type : Controlled Substance
Upfront Cash : Inapplicable
September 30, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Promethazine HCl and Dextromethorphan Hydrobromide-Generic is an approved oral solution, which is indicated for the patients suffering from cough.
Lead Product(s): Promethazine Hydrochloride,Dextromethorphan Hydrobromide
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Promethazine HCl-Dextromethorphan HBr-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 13, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Promethazine Hydrochloride,Dextromethorphan Hydrobromide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
ANI Pharmaceuticals Launches Oral Solution For Cough And Allergy Relief
Details : Promethazine HCl and Dextromethorphan Hydrobromide-Generic is an approved oral solution, which is indicated for the patients suffering from cough.
Product Name : Promethazine HCl-Dextromethorphan HBr-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 13, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
This diverse portfolio of products includes Breathe Right® Nasal Strips, the world’s #1 nasal strip, and Children’s Dimetapp®, the #1 pharmacist-recommended brand for children's cough and cold products, as well as Anbesol®, Alavert®, Dristan®, Primatene Tablets® and FiberCon®.
Lead Product(s): Brompheniramine Maleate,Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Dimetapp
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Foundation Consumer Healthcare
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 16, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Brompheniramine Maleate,Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Foundation Consumer Healthcare
Deal Size : Undisclosed
Deal Type : Agreement
Details : This diverse portfolio of products includes Breathe Right® Nasal Strips, the world’s #1 nasal strip, and Children’s Dimetapp®, the #1 pharmacist-recommended brand for children's cough and cold products, as well as Anbesol®, Alavert®, Dristan®, P...
Product Name : Dimetapp
Product Type : Miscellaneous
Upfront Cash : Undisclosed
July 16, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cough.
Lead Product(s): Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 08, 2016

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Dextromethorphan Pediatric Acute Cough Study
Details : Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cough.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
January 08, 2016

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pseudobulbar Palsy.
Lead Product(s): Dextromethorphan Hydrobromide,Quinidine
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 14, 2015

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Dextromethorphan Hydrobromide,Quinidine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With P...
Details : Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pseudobulbar Palsy.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
July 14, 2015

Details:
Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthritis, Rheumatoid.
Lead Product(s): Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area: Immunology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Controlled Substance
Sponsor: TSH Biopharm Corporation Limited
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 20, 2015

Lead Product(s) : Dextromethorphan Hydrobromide,Inapplicable
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : TSH Biopharm Corporation Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis
Details : Dextromethorphan HBr is a Controlled Substance drug candidate, which is currently being evaluated in clinical studies for the treatment of Arthritis, Rheumatoid.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Inapplicable
February 20, 2015

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
BIRT 2584 XX is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): BIRT 2584 XX,Warfarin Sodium,Omeprazole,Dextromethorphan Hydrobromide,Caffeine,Midazolam Hydrochloride,Vitamin K1
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 06, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : BIRT 2584 XX,Warfarin Sodium,Omeprazole,Dextromethorphan Hydrobromide,Caffeine,Midazolam Hydrochloride,Vitamin K1
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : BIRT 2584 XX is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 06, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Common Cold.
Lead Product(s): Paracetamol,Pseudoephedrine Hydrochloride,Dextromethorphan Hydrobromide,Chlorpheniramine Maleate
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Sino-American Tianjin Smith Kline & French Laboratories Ltd
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 22, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Paracetamol,Pseudoephedrine Hydrochloride,Dextromethorphan Hydrobromide,Chlorpheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Sino-American Tianjin Smith Kline & French Laboratories Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Common Cold.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 22, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Tipranavir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s):
Tipranavir,Ritonavir,Caffeine,Warfarin Sodium,Vitamin K1,Omeprazole,Dextromethorphan Hydrobromide,Midazolam,
Therapeutic Area: Undisclosed
Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous Sponsor:
Undisclosed
Deal Size: Inapplicable
Upfront Cash: Inapplicable
Deal Type: Inapplicable
September 18, 2014

Details : Tipranavir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 18, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Faldaprevir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Faldaprevir,Caffeine,Warfarin Sodium,Vitamin K1,Omeprazole,Dextromethorphan Hydrobromide,Midazolam Hydrochloride,Digoxin
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 08, 2014

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Faldaprevir,Caffeine,Warfarin Sodium,Vitamin K1,Omeprazole,Dextromethorphan Hydrobromide,Midazolam Hydrochloride,Digoxin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Faldaprevir is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2014

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Sinuclear Cough Syrup
Dosage Form : SOL
Dosage Strength : 10mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML
Packaging :
Approval Date : 2018-12-04
Application Number : 207676
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : OTC
Registration Country : USA
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Brand Name : GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG;600MG
Packaging :
Approval Date : 2023-08-01
Application Number : 217340
Regulatory Info : OTC
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : OTC
Registration Country : USA
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Brand Name : GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG;1.2GM
Packaging :
Approval Date : 2023-08-01
Application Number : 217340
Regulatory Info : OTC
Registration Country : USA
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Paracetamol; Caffeine; Phenylephrine Hydrochloride; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide
Brand Name : Paracetamol; Caffeine; Phenylephrine Hydrochloride; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide
Dosage Form : Tablet
Dosage Strength : 500MG; 30MG; 10MG; 2MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : DIMETANE-DX
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-08-24
Application Number : 19279
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
Brand Name : PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 15MG/5ML;6.25MG/5ML
Packaging :
Approval Date : 1984-04-02
Application Number : 11265
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
Brand Name : NUEDEXTA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 20MG;10MG
Packaging :
Approval Date : 2010-10-29
Application Number : 21879
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
Brand Name : DELSYM
Dosage Form : SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 30MG HYDROBROMIDE/5ML
Packaging :
Approval Date : 1982-10-08
Application Number : 18658
Regulatory Info : OTC
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : USA
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Brand Name : MUCINEX DM
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG;1.2GM
Packaging :
Approval Date : 2004-04-29
Application Number : 21620
Regulatory Info : OTC
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML
Approval Date : 2018-12-04
Application Number : 207676
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Brand Name : GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG;600MG
Approval Date : 2023-08-01
Application Number : 217340
RX/OTC/DISCN : OTC
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Brand Name : GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG;1.2GM
Approval Date : 2023-08-01
Application Number : 217340
RX/OTC/DISCN : OTC
RLD : No
TE Code :
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML
Approval Date : 2016-09-20
Application Number : 203375
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : DIMETANE-DX
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1984-08-24
Application Number : 19279
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML
Approval Date : 2020-07-14
Application Number : 210647
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : DEXTROMETHORPHAN POLISTIREX
Dosage Form : SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 30MG HYDROBROMIDE/5ML
Approval Date : 2017-07-28
Application Number : 203133
RX/OTC/DISCN : OTC
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : DELSYM
Dosage Form : SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 30MG HYDROBROMIDE/5ML
Approval Date : 1982-10-08
Application Number : 18658
RX/OTC/DISCN : OTC
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Brand Name : BROMFED-DM
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML;10MG/5ML;30MG/5ML
Approval Date : 1988-12-22
Application Number : 89681
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
Brand Name : PHERAZINE DM
Dosage Form : SYRUP;ORAL
Dosage Strength : 15MG/5ML;6.25MG/5ML
Approval Date : 1987-03-02
Application Number : 88913
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Paracetamol; Chlorphenamine Maleate; Phenylephrine Hydrochloride; Vitamin C; Dextrometorphan Hydrobromide
Brand Name : Propalgina Plus Powder For Oral Solution
Dosage Form : Oral Solution
Dosage Strength :
Packaging :
Approval Date : 1987-03-01
Application Number : 56999
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Cancelled
Registration Country : Spain
Paracetamol; Pseudoephedrine Sulfate; Dextromethorphan Hydrobromide
Brand Name : Larobeta
Dosage Form : Powder For Oral Solution
Dosage Strength : 500MG; 30MG; 15 MG
Packaging :
Approval Date : 2012-04-15
Application Number : 75767
Regulatory Info : Cancelled
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Cancelled
Registration Country : Spain
Sodium Benzoate; Dextromethorphan Hydrobromide
Brand Name : Dr. Andreu'S Pills
Dosage Form : Lozenge
Dosage Strength : 2MG; 15 MG
Packaging :
Approval Date : 1989-06-01
Application Number : 57875
Regulatory Info : Cancelled
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Dextromethorphan Hydrobromide; Diphenhydramine Hydrochloride
Brand Name : Cinfatos Night
Dosage Form : Solution
Dosage Strength : 1.33MG; 2MG
Packaging :
Approval Date : 2020-12-22
Application Number : 85664
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Cinfatos
Dosage Form : Oral Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 1988-07-01
Application Number : 57623
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Paracetamol; Chlorphenamine Maleate; Dextromethorphan Hydrobromide
Brand Name : Normogrip Antitusive Granulated For Oral Solution
Dosage Form : Oral Solution
Dosage Strength :
Packaging :
Approval Date : 2023-03-01
Application Number : 88698
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Minustosan
Dosage Form : Syrup
Dosage Strength : 1.5MG
Packaging :
Approval Date : 2021-06-04
Application Number : 84688
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorised
Registration Country : Malta
Paracetamol; Pseudoephedrine Hydrochloride; Dextromethorphan Hydrobromide
Brand Name : Daleron Cold3
Dosage Form : Film Coated Tablet
Dosage Strength : 325MG; 30MG; 15MG
Packaging :
Approval Date : 2022-01-07
Application Number :
Regulatory Info : Authorised
Registration Country : Malta

Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Aurotos
Dosage Form : Oral Solution
Dosage Strength : 15MG
Packaging :
Approval Date : 2014-04-11
Application Number : 78676
Regulatory Info : Cancelled
Registration Country : Spain

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Laitos
Dosage Form : Syrup
Dosage Strength : 3MG
Packaging :
Approval Date : 2009-06-03
Application Number : 70997
Regulatory Info : Authorized
Registration Country : Spain

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BUCKLEY'S COLD & SINUS 24 HOUR PACK
Dosage Form : KIT
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 2493802
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BUCKLEY'S DRY COUGH EXTRA STRENGTH
Dosage Form : SOLUTION
Dosage Strength : 15MG/5ML
Packaging :
Approval Date :
Application Number : 2511320
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BENYLIN EXTRA STRENGTH DRY COUGH
Dosage Form : SYRUP
Dosage Strength : 30MG/10ML
Packaging : 100ML/250ML
Approval Date :
Application Number : 1944738
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CHILDREN'S TYLENOL COLD AND COUGH
Dosage Form : SUSPENSION
Dosage Strength : 7.5MG/5ML
Packaging : 100ML
Approval Date :
Application Number : 2039990
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU
Dosage Form : SYRUP
Dosage Strength : 15MG/15ML
Packaging : 180 ML
Approval Date :
Application Number : 2245710
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION
Dosage Form : SYRUP
Dosage Strength : 15MG/5ML
Packaging : 100ML/250ML
Approval Date :
Application Number : 2265419
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : NYQUIL KIDS COUGH & COLD
Dosage Form : SYRUP
Dosage Strength : 15MG/15ML
Packaging :
Approval Date :
Application Number : 2273330
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : NYQUIL COLD & FLU ALCOHOL FREE
Dosage Form : SYRUP
Dosage Strength : 30MG/30ML
Packaging :
Approval Date :
Application Number : 2551667
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : COLD AND FLU-IN-ONE EXTRA STRENGTH
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging : Dec-24
Approval Date :
Application Number : 2281147
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : COLD AND SINUS COMPLETE LIQUID GELS
Dosage Form : CAPSULE
Dosage Strength : 10MG
Packaging : 10/20/30/40
Approval Date :
Application Number : 2349523
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Sinuclear Cough Syrup
Dosage Form : SOL
Dosage Strength : 10mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Sinustat Flu Syrup
Dosage Form : SYR
Dosage Strength : 15mg
Packaging : 200X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Dilinct Dry Cough Syrup
Dosage Form : SYR
Dosage Strength : 15mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Dilinct Dry Cough Syrup
Dosage Form : SYR
Dosage Strength : 15mg/5ml
Packaging : 200X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cepacol Sore Throat And Cough Relief Discs
Dosage Form : LOZ
Dosage Strength : 4.98mg
Packaging : 16X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Broncol Cough Linctus
Dosage Form : SYR
Dosage Strength : 30mg/10 ml
Packaging : 200X1mg/10 ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Broncol Cough Linctus
Dosage Form : SYR
Dosage Strength : 30mg/10 ml
Packaging : 100X1mg/10 ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Demazin Flu
Dosage Form : EFT
Dosage Strength : 20mg
Packaging : 12X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Benylin Dry Cough
Dosage Form : SYR
Dosage Strength : 15mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Benylin Dry Cough
Dosage Form : SYR
Dosage Strength : 15mg/5ml
Packaging : 200X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
52
PharmaCompass offers a list of Dextromethorphan Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dextromethorphan Hydrobromide manufacturer or Dextromethorphan Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dextromethorphan Hydrobromide manufacturer or Dextromethorphan Hydrobromide supplier.
PharmaCompass also assists you with knowing the Dextromethorphan Hydrobromide API Price utilized in the formulation of products. Dextromethorphan Hydrobromide API Price is not always fixed or binding as the Dextromethorphan Hydrobromide Price is obtained through a variety of data sources. The Dextromethorphan Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dextromethorphan hydrobromide anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dextromethorphan hydrobromide anhydrous, including repackagers and relabelers. The FDA regulates Dextromethorphan hydrobromide anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dextromethorphan hydrobromide anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dextromethorphan hydrobromide anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dextromethorphan hydrobromide anhydrous supplier is an individual or a company that provides Dextromethorphan hydrobromide anhydrous active pharmaceutical ingredient (API) or Dextromethorphan hydrobromide anhydrous finished formulations upon request. The Dextromethorphan hydrobromide anhydrous suppliers may include Dextromethorphan hydrobromide anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dextromethorphan hydrobromide anhydrous DMF (Drug Master File) is a document detailing the whole manufacturing process of Dextromethorphan hydrobromide anhydrous active pharmaceutical ingredient (API) in detail. Different forms of Dextromethorphan hydrobromide anhydrous DMFs exist exist since differing nations have different regulations, such as Dextromethorphan hydrobromide anhydrous USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dextromethorphan hydrobromide anhydrous DMF submitted to regulatory agencies in the US is known as a USDMF. Dextromethorphan hydrobromide anhydrous USDMF includes data on Dextromethorphan hydrobromide anhydrous's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dextromethorphan hydrobromide anhydrous USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dextromethorphan hydrobromide anhydrous Drug Master File in Japan (Dextromethorphan hydrobromide anhydrous JDMF) empowers Dextromethorphan hydrobromide anhydrous API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dextromethorphan hydrobromide anhydrous JDMF during the approval evaluation for pharmaceutical products. At the time of Dextromethorphan hydrobromide anhydrous JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Dextromethorphan hydrobromide anhydrous Drug Master File in Korea (Dextromethorphan hydrobromide anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Dextromethorphan hydrobromide anhydrous. The MFDS reviews the Dextromethorphan hydrobromide anhydrous KDMF as part of the drug registration process and uses the information provided in the Dextromethorphan hydrobromide anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a Dextromethorphan hydrobromide anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Dextromethorphan hydrobromide anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with KDMF on PharmaCompass.
A Dextromethorphan hydrobromide anhydrous CEP of the European Pharmacopoeia monograph is often referred to as a Dextromethorphan hydrobromide anhydrous Certificate of Suitability (COS). The purpose of a Dextromethorphan hydrobromide anhydrous CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dextromethorphan hydrobromide anhydrous EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dextromethorphan hydrobromide anhydrous to their clients by showing that a Dextromethorphan hydrobromide anhydrous CEP has been issued for it. The manufacturer submits a Dextromethorphan hydrobromide anhydrous CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dextromethorphan hydrobromide anhydrous CEP holder for the record. Additionally, the data presented in the Dextromethorphan hydrobromide anhydrous CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dextromethorphan hydrobromide anhydrous DMF.
A Dextromethorphan hydrobromide anhydrous CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dextromethorphan hydrobromide anhydrous CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with CEP (COS) on PharmaCompass.
A Dextromethorphan hydrobromide anhydrous written confirmation (Dextromethorphan hydrobromide anhydrous WC) is an official document issued by a regulatory agency to a Dextromethorphan hydrobromide anhydrous manufacturer, verifying that the manufacturing facility of a Dextromethorphan hydrobromide anhydrous active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dextromethorphan hydrobromide anhydrous APIs or Dextromethorphan hydrobromide anhydrous finished pharmaceutical products to another nation, regulatory agencies frequently require a Dextromethorphan hydrobromide anhydrous WC (written confirmation) as part of the regulatory process.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dextromethorphan hydrobromide anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dextromethorphan hydrobromide anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dextromethorphan hydrobromide anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dextromethorphan hydrobromide anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dextromethorphan hydrobromide anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dextromethorphan hydrobromide anhydrous suppliers with NDC on PharmaCompass.
Dextromethorphan hydrobromide anhydrous Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dextromethorphan hydrobromide anhydrous GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dextromethorphan hydrobromide anhydrous GMP manufacturer or Dextromethorphan hydrobromide anhydrous GMP API supplier for your needs.
A Dextromethorphan hydrobromide anhydrous CoA (Certificate of Analysis) is a formal document that attests to Dextromethorphan hydrobromide anhydrous's compliance with Dextromethorphan hydrobromide anhydrous specifications and serves as a tool for batch-level quality control.
Dextromethorphan hydrobromide anhydrous CoA mostly includes findings from lab analyses of a specific batch. For each Dextromethorphan hydrobromide anhydrous CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dextromethorphan hydrobromide anhydrous may be tested according to a variety of international standards, such as European Pharmacopoeia (Dextromethorphan hydrobromide anhydrous EP), Dextromethorphan hydrobromide anhydrous JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dextromethorphan hydrobromide anhydrous USP).